Immatics N.V. (IMTX)
NASDAQ: IMTX · IEX Real-Time Price · USD
12.02
+0.02 (0.17%)
At close: Jul 2, 2024, 4:00 PM
12.00
-0.02 (-0.17%)
After-hours: Jul 2, 2024, 7:00 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.24 billion as of July 2, 2024. Its market cap has increased by 38.79% in one year.
Market Cap
1.24B
Enterprise Value
648.42M
1-Year Change
38.79%
Ranking
Category
Stock Price
$12.02
Market Cap Chart
Since October 5, 2018, Immatics's market cap has increased from $127.10M to $1.24B, an increase of 874.58%. That is a compound annual growth rate of 48.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.24B | 38.73% |
| Dec 29, 2023 | 891.40M | 55.92% |
| Dec 30, 2022 | 571.70M | -32.38% |
| Dec 31, 2021 | 845.50M | 336.05% |
| Dec 31, 2020 | 193.90M | 3.75% |
| Dec 31, 2019 | 186.90M | 6.13% |
| Dec 31, 2018 | 176.10M | 38.55% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omnicell | 1.24B |
| Phreesia | 1.22B |
| Vir Biotechnology | 1.21B |
| Sana Biotechnology | 1.21B |
| Day One Biopharmaceuticals | 1.20B |
| Spyre Therapeutics | 1.19B |
| Xencor | 1.17B |
| Verona Pharma | 1.12B |